Back to Search
MOGAHED HUSSEIN, MD
MD
Critical Care Medicine (Anesthesiology) Physician
NPI: 1295569473Individual
Specialties, Licenses & Credentials
Critical Care Medicine (Anesthesiology) PhysicianPrimary
Anesthesiology — Critical Care Medicine
Code: 207LC0200X
57.257337(OH)
Research & Publications (20)
Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.
PMID 16732369·Thromb Haemost·2006
6-review
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma.
PMID 16835968·Mayo Clin Proc·2006
3-trial
Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis.
PMID 16138931·Int Semin Surg Oncol·2005
8-other
Multiple myeloma: an update of developments in targeted therapy.
PMID 15877532·Expert Rev Anticancer Ther·2005
6-review
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.
PMID 16193091·Leukemia·2005
3-trial
Thalidomide: present and future in multiple myeloma.
PMID 15757435·Expert Rev Anticancer Ther·2005
6-review
Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma.
PMID 15142117·Br J Haematol·2004
3-trial
Role of liposomal anthracyclines in the treatment of multiple myeloma.
PMID 15717741·Semin Oncol·2004
6-review
Skeletal trauma preceding the development of plasma cell dyscrasia: eight case reports and review of the literature.
PMID 14716030·Med Oncol·2003
5-case
Modifications to therapy for multiple myeloma: pegylated liposomal Doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomide.
PMID 14671227·Oncologist·2003
3-trial
Pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone as first-line therapy for multiple myeloma.
PMID 14556672·Clin Lymphoma·2003
6-review
Etanercept therapy in patients with advanced primary amyloidosis.
PMID 14514978·Med Oncol·2003
8-other
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.
PMID 12412170·Cancer·2002
3-trial
Nontraditional cytotoxic therapies for relapsed/refractory multiple myeloma.
PMID 11961206·Oncologist·2002
6-review
Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi.
PMID 11437939·J Cutan Pathol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE, SUITE RC25
CLEVELAND, OH 44195 - Phone
- (216) 444-2200
Quick Facts
- NPI
- 1295569473
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile